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Abstract 
Background: To present a rare case of a 2-year-old girl with neurofibromatosis type 1 (NF1) 
who presented with ptosis of the right upper eyelid along with a tumor in the eyelid. Meth-
ods: A magnetic resonance imaging scan of the orbit revealed a solid tumor located extraco-
nally at the site of the right lacrimal gland. A transcranial orbitotomy was performed. Results: 
Histopathological examination demonstrated expanded nerve branches/fascicles cut in vari-
ous planes in between normal lacrimal gland acini. These findings were consistent with a 
plexiform neurofibroma presumably deriving from the lacrimal nerve and/or a supraorbital 
nerve branch. Conclusion: This is the first case of a plexiform neurofibroma involving the 
lacrimal gland ever described and the tumor shows similarities with neurofibroma in other 
salivary glands with a high recurrence rate. Plexiform neurofibromas are frequently seen in 
patients with NF1 and rarely undergo malignant transformation. 
 © 2017 The Author(s) 
 Published by S. Karger AG, Basel 
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Introduction 
Neurofibromatosis type 1 (NF1) has a prevalence of 1:2,500 to 1:3,500 people, regard-
less of ethnic and racial background and is inherited in an autosomal dominant manner that 
exhibits complete penetrance [1]. Half of the cases are a result of a sporadic gene mutation 
[1]. The NF1 gene is located at the long arm of chromosome 17 [1]. Inactivating mutations of 
NF1 cause a decrease in the amount of the gene product, neurofibromin, and lead to in-
creased intracellular signaling through Ras [1]. 
The National Institutes of Health (NIH) [2] developed in 1987 the diagnostic criteria for 
NF1, and updated them in 1997 [3]. An individual meets the criteria of having NF1 and 
should be diagnosed if 2 or more specific features are present (Table 1) [2]. The diagnosis of 
NF1 can in most cases be made based on these criteria; in rare cases, it is necessary to pur-
sue genetic testing [1]. 
Peripheral nerve sheath tumors (PNST) often involve the neck and head region, but are 
uncommon in the orbit [4]. Plexiform neurofibromas, in contrast to other PNST, are diag-
nosed in early life between the age of 1 and 5 years [4]. Plexiform neurofibromas of the sali-
vary gland are rare, but when present, they are commonly located in the parotid gland [5]. 
They are locally invasive tumors and not prone to metastasizing [6]. 
This case is the only reported case of a plexiform neurofibroma involving the lacrimal 
gland. 
Materials and Methodology 
A 2-year-old girl presented to the clinic with ptosis of the right upper eyelid that had 
persisted since the age of 3–4 months. The girl was first seen by an ophthalmologist at the 
age of 1 year due to ptosis of the right eyelid. The pupil was free of the right-sided ptosis, but 
the ptosis progressed. The patient had a twin sister without symptoms and no other family 
disposition to ptosis. At the time of referral (December 1998) NF1 was suspected because of 
the presence of café-au-lait spots on the skin of the abdomen and thorax. 
The initial clinical examination revealed no signs of strabismus, and the motility of both 
eyes was normal. There was significant ptosis of the right upper eyelid covering most of the 
cornea, but the patient was able to elevate the eyelid 3 mm over the upper edge of the pupil. 
There was a characteristic s-shaped deformity of the right upper eyelid typical of NF1, and 
the eyelid was soft on palpation (Fig. 1A). The left eye was normal. Ophthalmoscopy was 
performed at a later consultation and was normal in both eyes. Magnetic resonance imaging 
(MRI) scans of the cerebrum and the orbit were performed and showed exophthalmus and a 
solid tumor, 1 cm at the largest axis, located extraconally at the site of the lacrimal gland and 
highly suggestive of a plexiform neurofibroma or a lacrimal gland tumor (Fig. 1B). No sign of 
optic pathway glioma, infiltration of the eye or the bone was found. 
In June 1999, the tumor was excised in toto by transcranial orbitotomy, and orbital roof 
reconstruction was performed in the same operation 6 months after the first consultation. 
On clinical examination 2 months after surgery, the ptosis was reduced to a mild/moderate 
type. The shape of the eyelid returned to normal. The right-sided ptosis was measured to 1–
2 mm, with a closing defect of 1 mm. Fourteen months after surgery, there was no change in 
D
ow
nl
oa
de
d 
by
: 
Co
pe
nh
ag
en
 U
ni
ve
rs
ity
 L
ib
ra
ry
   
   
   
   
   
   
   
   
  
13
0.
22
5.
17
8.
2 
- 8
/3
1/
20
17
 4
:1
2:
18
 P
M
 Case Rep Ophthalmol 2017;8:67–72 
DOI: 10.1159/000456067 © 2017 The Author(s). Published by S. Karger AG, Basel 
www.karger.com/cop 
Hofsli et al.: Plexiform Neurofibroma Involving the Lacrimal Gland 
 
 
 
 
69 
the patient’s ptosis compared with 2 months after surgery; besides, the closing defect had 
disappeared. Visual acuity (VA) was 0.25 bilaterally. 
In October 2005, the patient was again referred to the clinic on suspicion of tumor re-
currence. Clinical examination revealed a 3 × 1 cm freely movable tumor located subcutane-
ous at the lateral cantus. Based on the clinical examination, no orbital involvement was sus-
pected. The right eye was slightly downward displaced, and there was a 5° exotropia but 
normal motility. VA was 0.12 in the right eye and 0.66 in the left eye. Tear production was 
zero in the right eye. Levator function was 7/17 mm. Because of compromised tear produc-
tion, the patient received punctum plugs. It was decided to remove the tumor, and during 
surgery it was clear that the tumor consisted of 2 tumors (2 × 2 and 0.5 × 0.5 cm) located in 
the eyelid at the lateral side of the right eye. Both tumors were removed and histopathologi-
cal examination revealed recurrence of plexiform neurofibroma.  
The patient underwent ptosis surgery in November 2010, and in August 2013 re-ptosis 
surgery was performed with removal of fibroadenomatous tissue in the eyelid of the right 
eye. 
Results 
Histopathological Examination 
The specimen from the lacrimal gland measured 20 × 14 × 14 mm. Microscopical exami-
nation of the initial tumor showed nerve sheath proliferation confined within the perineuri-
um of multiple disorganized nerve fascicles. The nerve fascicles intermingled between the 
normal lacrimal acini. The nerve fibers were arranged in a concentric manner with areas of 
myxoid changes. The tumor was characterized by tortuous proliferation of all components of 
peripheral nerves including axons, Schwann cells, fibroblasts, and perineurial cells. The 
amount of normal lacrimal tissue constituted 10–15% (Fig. 1C, D). 
Immunohistochemically, the tumor cells stained positive for epithelial membrane anti-
gen (perineurium), neurofilament (residual axons), neuron-specific enolase, S-100 (Schwann 
cells), CD34 (admixed fibroblasts), and vimentin. Tumor cells stained negative for pan-
cytokeratin (CKAE-CAM) and Mib-1 (KI-67). The histological features were consistent with a 
plexiform neurofibroma presumably deriving from the lacrimal nerve and/or a supraorbital 
nerve branch. 
Discussion 
The most common tumor found in the lacrimal gland is pleomorphic adenoma, but a 
spectrum of lymphoid tumors may also develop [7]. In a Danish study, a total of 232 lesions 
were characterized [8]. Approximately half of the lesions were neoplasms, and half of these 
were malignant [8]. 
PNST can involve the nerve fascicles or cranial branches II–VII in the orbit [4]. Plexi-
form neurofibromas in NF1 often present in childhood or adolescence with a characteristic 
s-shaped curvature and swelling of the upper eyelid [4]. Orbitotemporal neurofibromatosis 
(OTNF) is a condition where patients develop grossly disfiguring neurofibromas of the orbit, 
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temporal and facial region with onset in childhood [9]. Our patient had lacrimal gland and 
eyelid involvement, without absence or involvement of the sphenoid bone which is a charac-
teristic skeletal abnormality in OTNF [9]. 
Neurofibromas constitute 0.4% of all salivary neoplasms [10]. Plexiform neurofibromas 
are slow-growing, locally infiltrating benign tumors [10]. They arise from diffuse enlarge-
ment of multiple nerve fascicles and its branches, resulting in nerve thickening [10]. Due to 
their locally invasive nature, they can cause cosmetic and functional deformities in the head 
and neck region [6]. 
Plexiform neurofibromas are common in patients with NF1 (30–50%), but only in 5–
10% of cases does the tumor undergo malignant transformation [1]. Plexiform neurofibro-
mas of the salivary glands are most commonly reported in the parotid gland [5, 11, 12]. 
Submandibular salivary gland neurofibromas are rare [11]. There has been 1 reported case 
of an isolated neurofibrosarcoma of the lacrimal gland in the literature [13]. This is the first 
described plexiform neurofibroma involving the lacrimal gland. 
In the management of orbitotemporal NF1, no firm guidelines are currently established 
[4]. Children and adolescents typically experience rapid growth of neurofibromatosis and 
should remain under close observation, monitoring their visual development to allow timely 
intervention with appropriate surgical procedures [4, 14]. The risk of developing amblyopia 
in children should always be taken into consideration [4]. In our case, the patient developed 
amblyopia, probably because of severe ptosis for several years, leading to a compromised VA 
of the right eye. All treatments need to be individualized and should ideally be managed 
through a multidisciplinary medical approach [4, 14]. 
The treatment of choice for benign neurofibromas is complete excision with intact tu-
mor capsule [4]. Lateral orbitotomy is commonly used when the tumor is located supero-
laterally [4]. Plexiform neurofibromas often present with diffuse soft tissue infiltration, 
which makes complete resection difficult [9]. Only the rare, well-circumscribed neurofibro-
mas can be removed intact through an anterolateral orbitotomy [9]. Debulking surgery for 
plexiform neurofibromas should only be performed in special cases, due to the tendency to 
recur when only partly removed [4]. Our patient initially underwent transcranial orbitoto-
my, as the operation was performed by neurosurgeons. Multiple tumor recurrences devel-
oped in the present case. 
In summary, neurofibroma involving the lacrimal gland is extremely rare, and shows 
similarities with lesions in other salivary glands. This is the first reported case of a plexiform 
neurofibroma involving the lacrimal gland. Plexiform neurofibromas are frequently seen in 
patients with NF1. 
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Fig. 1. A Initial clinical photograph of the patient (2 years of age) showing ptosis of the right eyelid and a 
solid mass located on the right upper lid. B Magnetic resonance imaging scan of the cerebrum and orbit 
revealing a solid tumor located extraconally at the site of the right lacrimal gland (arrow). C Markedly 
enlarged nerve segments and thickened nerve bundles (*) within the lacrimal gland tissue (arrow). Hema-
toxylin and eosin section. Scale bar = 1:200 µm. D Higher magnification showing bundles of nerve fibers 
arranged in a concentric manner with areas of myxoid changes. Schwann cells and fibroblasts are seen. 
Hematoxylin and eosin section. Scale bar = 1:200 µm. Normal lacrimal gland tissue (arrow) is seen be-
tween the nerve fiber bundles (*). 
 
 
 
 
Table 1. The diagnostic criteria for NF1 developed by the National Institutes of Health (NIH) in 1987 [2] 
  
  
1. Six or more café-au-lait spots >5 mm in greatest diameter in prepubertal individuals; and >15 mm in 
greatest diameter in postpubertal individuals 
2. Two or more neurofibromas of any type or 1 plexiform neurofibroma 
3. Freckling in the axillary or inguinal regions 
4. Optic glioma 
5. Two or more Lisch nodules (iris harmartomas) 
6. A distinctive osseous lesion such as sphenoid dysplasia or thinning of long bone cortex with or without 
pseudoarthrosis 
7. A first-degree relative (parent, sibling, or offspring) with neurofibromatosis by the above criteria 
  
  
The criteria are met in an individual if two or more of the features listed are present.  
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